Welcome to our dedicated page for JBT Marel SEC filings (Ticker: JBTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the real cost of JBT Marel Corp’s next-generation protein and produce lines means digging through hundreds of pages that blend engineering jargon with complex revenue-recognition rules. If you have ever searched "JBT Marel SEC filings explained simply" or wondered how service contracts flow through their balance sheet, you know the challenge.
Stock Titan solves it. Our AI instantly translates each 10-K annual report into plain language, highlights backlog shifts in the FoodTech segment, and flags warranty reserve changes right next to the numbers. Need the "JBT Marel quarterly earnings report 10-Q filing"? It arrives here seconds after EDGAR posts. Curious about "JBT Marel insider trading Form 4 transactions"? We stream "JBT Marel Form 4 insider transactions real-time" so you can spot executive stock moves before the market reacts. For sudden contract wins we attach concise notes to every "JBT Marel 8-K material events explained" entry, while proxy links answer "JBT Marel proxy statement executive compensation" questions without page-hunting.
All filings live in one place, covered by AI-powered summaries, keyword search and red-flag alerts that surface:
- Segment revenue swings and margin drivers
- Capital expenditure on robotics plants
- Deferred revenue tied to multi-year service deals
- "JBT Marel executive stock transactions Form 4" patterns
Whether you’re comparing quarter-over-quarter performance or learning how lease accounting affects cash flow, our platform turns dense disclosures into actionable clarity. Stop combing PDFs—start "understanding JBT Marel SEC documents with AI" in minutes.
JBT Marel Corp director reports open-market stock sales. A reporting person who serves as a director of JBT Marel Corp (ticker JBTM) disclosed selling a total of 20,000 shares of common stock on 11/26/2025 in two transactions. One sale involved 19,870 shares at a weighted average price of $141.79 per share, within a trading range of $141.26 to $142.225. A second sale covered 130 shares at a weighted average price of $142.51, within a range of $142.315 to $142.60.
After these sales, the director directly owned 19,980 shares of JBT Marel common stock. The filing also lists additional indirect holdings of 98,407 and 8,128 shares held through Noruz ehf and related entities, which are largely owned via a family trust. The reporting person disclaims beneficial ownership of these indirect shares except to the extent of their economic interest.
JBTM has a Form 144 filing indicating an intended sale of 30,000 shares of common stock through The Charles Schwab Corporation on or after 11/26/2025 on the NYSE. The planned sale has an aggregate market value of $4,326,864, while 51,971,372 shares of the issuer’s stock are reported as outstanding. The seller acquired these 30,000 shares on 01/02/2025 in a stock merger transaction with the issuer. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about JBTM’s current or future operations.
JBT Marel Corporation (NYSE: JBTM) reported Q3 2025 results reflecting the first full quarters with Marel. Revenue rose to $1,001.3 million from $453.8 million a year ago, and operating income increased to $102.1 million from $46.8 million. Net income was $66.0 million versus $38.9 million in Q3 2024, while diluted EPS was $1.26 versus $1.21.
For the first nine months, the company posted a net loss of $103.6 million, driven by a $146.9 million pension settlement charge, acquisition-related costs, and higher interest expense. Cash from continuing operations was $224.3 million. Cash, cash equivalents and restricted cash ended at $133.3 million.
JBT closed the $4.27 billion Marel acquisition on January 2, 2025, recognizing $2.31 billion of goodwill and $2.62 billion of intangible assets at September 30, 2025. Total assets were $8,199.4 million and equity was $4,420.8 million. Debt totaled $1,905.4 million, including a $900 million Term Loan B and $575.0 million of 2030 convertible notes. Shares outstanding were 51,971,372 as of October 30, 2025. The company corrected immaterial cash flow presentation errors from earlier 2025 periods.
JBT Marel Corporation furnished an 8-K announcing it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information under Item 2.02 is furnished, not filed, and is not subject to Section 18 liabilities; it will not be incorporated by reference into other filings except as expressly stated. The company’s common stock trades on the NYSE under the symbol JBTM.
JBT Marel Corporation announced the resignation of Vice President, Corporate Controller and Chief Accounting Officer, Jessi L. Corcoran, effective November 4, 2025. The company stated her departure follows acceptance of a role at another company and is not due to any disagreement regarding operations, policies, accounting principles, financial disclosures, or internal controls.
The Board designated Executive Vice President and Chief Financial Officer Matthew J. Meister to serve as principal accounting officer effective upon Ms. Corcoran’s departure. The company noted no additional compensation for Mr. Meister related to this designation and disclosed no related-party arrangements.
On 10/01/2025, reporting person Luiz Augusto Rizzolo, identified as EVP & Pres., Regions & Int. of JBT Marel Corp (JBTM), reported a sale of 546 shares of common stock at a price of $141.12 per share. After the transaction he beneficially owned 5,796 shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
JBT Marel Corporation filed an 8-K reporting a material financing event tied to a convertible note offering and related hedging instruments. The filing attaches an Indenture dated
The documents indicate the company completed the legal and disclosure steps for the offering and associated derivatives (bond hedge and warrant confirmations). Signatory information shows Matthew J. Meister signed as Executive Vice President and Chief Financial Officer. The filing does not disclose the offering size, proceeds, or use of proceeds within the provided text.
JBT Marel Corporation filed an 8-K reporting several exhibits related to the Marel transaction. The filing includes a Second Amendment to the Second Amended and Restated Credit Agreement dated September 3, 2025, a press release announcing the launch of the Offering dated the same day, and unaudited pro forma condensed combined financial information reflecting the Marel Transaction, including a pro forma statement of income for the year ended December 31, 2024 and accompanying notes. Management’s Discussion and Analysis for Marel and an Inline XBRL cover page interactive data file are also furnished. The filing is signed by Matthew J. Meister.
FAQ
What is the current stock price of JBT Marel (JBTM)?
What is the market cap of JBT Marel (JBTM)?
